Patent ID: 11919881
Assignee: JANSSEN PHARMACEUTICA NV
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC C

Claim 5:
6. The compound of claim 5, wherein
R1 is selected from the group consisting of 1,2,3,4-tetrazol-1-yl, 4-chloro-1,2,3-triazol-1-yl and 4-(trifluoromethyl)-1,2,3-triazol-1-yl;
a is 2; one R2 is 5-chloro and one R2 is 6-fluoro;
R4 is selected from the group consisting of pyridin-4-yl, 1-(methyl-d3)-pyrazol-5-yl, 1-methyl-1,2,3-triazol-5-yl and 1-(difluoro-methyl)-1,2,4-triazol-5-yl;
R5 is selected from the group consisting of 4-fluorophenyl-methyl-, S*-(2-(difluoromethoxy)-ethyl-), and R-(2-(difluoromethoxy)-ethyl-);
R6 is hydrogen;
R7 is hydrogen;
or a pharmaceutically acceptable salt or solvate thereof.